88 related articles for article (PubMed ID: 27166996)
1. MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.
Tong D; Zhao L; He K; Sun H; Cai D; Ni L; Sun R; Chang S; Song T; Huang C
Oncotarget; 2016 Jun; 7(23):34845-59. PubMed ID: 27166996
[TBL] [Abstract][Full Text] [Related]
2. Methyl-CpG-binding protein 2 regulates CYP27A1-induced myometrial contraction during preterm labor.
Peng T; Cui J; Ni Z; Tang Y; Cao X; Li S; Cheng X; Huang J
Mol Hum Reprod; 2024 May; 30(6):. PubMed ID: 38704863
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of miR-98 and unraveling regulatory mechanisms in gestational diabetes mellitus.
Cao JL; Zhang L; Li J; Tian S; Lv XD; Wang XQ; Su X; Li Y; Hu Y; Ma X; Xia HF
Sci Rep; 2016 Aug; 6():32268. PubMed ID: 27573367
[TBL] [Abstract][Full Text] [Related]
4. Methylated Nucleotide-Based Proteolysis-Targeting Chimera Enables Targeted Degradation of Methyl-CpG-Binding Protein 2.
Wang Z; Liu J; Qiu X; Zhang D; Inuzuka H; Chen L; Chen H; Xie L; Kaniskan HÜ; Chen X; Jin J; Wei W
J Am Chem Soc; 2023 Oct; 145(40):21871-21878. PubMed ID: 37774414
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of pericentric HSATII RNA results in nuclear RNA accumulation, MeCP2 recruitment, and cell division defects.
Landers CC; Rabeler CA; Ferrari EK; D'Alessandro LR; Kang DD; Malisa J; Bashir SM; Carone DM
Chromosoma; 2021 Mar; 130(1):75-90. PubMed ID: 33585981
[TBL] [Abstract][Full Text] [Related]
6. Correction to: ``MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells''.
Glycobiology; 2024 Mar; 34(1):. PubMed ID: 38279617
[No Abstract] [Full Text] [Related]
7. MiR-22, regulated by MeCP2, suppresses gastric cancer cell proliferation by inducing a deficiency in endogenous S-adenosylmethionine.
Tong D; Zhang J; Wang X; Li Q; Liu L; Lu A; Guo B; Yang J; Ni L; Qin H; Zhao L; Huang C
Oncogenesis; 2020 Nov; 9(11):99. PubMed ID: 33168819
[TBL] [Abstract][Full Text] [Related]
8. Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review.
Deng X; Wang J; Lu C; Zhou Y; Shen L; Ge A; Fan H; Liu L
Front Pharmacol; 2023; 14():1226629. PubMed ID: 37818185
[TBL] [Abstract][Full Text] [Related]
9. The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology.
Nejati-Koshki K; Roberts CT; Babaei G; Rastegar M
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345019
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis.
Wang G; Zhang Z; Xia C
Bioengineered; 2021 Dec; 12(2):9678-9691. PubMed ID: 34842045
[TBL] [Abstract][Full Text] [Related]
11. Molecular interactions of miR-338 during tumor progression and metastasis.
Moghbeli M
Cell Mol Biol Lett; 2021 Apr; 26(1):13. PubMed ID: 33827418
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide analysis reveals the MeCP2-dependent regulation of genes in BGC-823 cells.
Liu YX; Li LY; Diao ZJ; He YM; Chen Y; Hou N; Zhao LY; Huang C
Int J Clin Exp Pathol; 2020; 13(7):1578-1589. PubMed ID: 32782676
[TBL] [Abstract][Full Text] [Related]
13. LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p.
Yuan L; Ma T; Liu W; Chen Y; Yuan Q; Ye M; Yu L; Li J; Niu Y; Nan Y
Am J Transl Res; 2019; 11(10):6641-6649. PubMed ID: 31737214
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme.
Shaji SK; Sunilkumar D; Mahalakshmi NV; Kumar GB; Nair BG
Oncol Lett; 2019 Aug; 18(2):1938-1948. PubMed ID: 31423264
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation contributes to silencing the expression of linc00086 in gastric cancer.
Yang Y; Li Y; Zhao Z; Sun R; Jiang Q; Zhao L; Wang L; Liu Y; Wu F; Shi X; Huang C; Shao Y
Oncol Lett; 2018 Aug; 16(2):1931-1936. PubMed ID: 30008886
[TBL] [Abstract][Full Text] [Related]
16. Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest.
Yang L; Liu H; Long M; Wang X; Lin F; Gao Z; Zhang H
Onco Targets Ther; 2018; 11():2409-2417. PubMed ID: 29750041
[TBL] [Abstract][Full Text] [Related]
17. miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.
Zhu F; Wu Q; Ni Z; Lei C; Li T; Shi Y
Int J Mol Med; 2018 Jul; 42(1):228-236. PubMed ID: 29568890
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
[TBL] [Abstract][Full Text] [Related]
19. MECP2 expression in gastric cancer and its correlation with clinical pathological parameters.
Zhang J; Zhao J; Gao N; Wang Y; Chen Y; Han J
Medicine (Baltimore); 2017 Aug; 96(31):e7691. PubMed ID: 28767600
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of joint bioinformatics analysis of underlying potential of 'neurimmiR', miR-212-3P/miR-132-3P, being involved in epilepsy and its emerging role in human cancer.
Xia L; Li D; Lin C; Ou S; Li X; Pan S
Oncotarget; 2017 Jun; 8(25):40668-40682. PubMed ID: 28380454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
